Eradication of Acute Myeloid Leukemia Is Enhanced By Combined Bcl-2 and Mcl-1 Targeting

被引:2
|
作者
Teh, Tse-Chieh [1 ]
Nguyen, Nhu-Y [2 ]
Glaser, Stefan [3 ]
Moujalled, Donia [2 ]
Pomilio, Giovanna [2 ]
Huang, David C. S. [3 ]
Guthridge, Mark [2 ]
Wei, Andrew H. [2 ,4 ]
机构
[1] Monash Univ, Alfred Hosp, Melbourne, Vic 3181, Australia
[2] Monash Univ, Melbourne, Vic 3181, Australia
[3] Royal Melbourne Hosp, Walter & Eliza Hall Inst Med Res, Parkville, Vic 3050, Australia
[4] Alfred Hosp, Melbourne, Vic, Australia
关键词
D O I
10.1182/blood.V124.21.988.988
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页数:3
相关论文
共 50 条
  • [21] Synthesis and Biological Evaluation of Quercetagetin Derivatives as the Inhibitors of Mcl-1 and Bcl-2 Against Leukemia
    Li, Kang
    Ge, Xiaomei
    Liu, Wei
    Huang, Lei
    Lv, Xinye
    Tang, Yuhui
    He, Zhehao
    Yang, Yingxue
    Chen, Miaofen
    Zeng, Jianguo
    Cheng, Pi
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2025, 26 (06)
  • [22] Key Survival Factor, Mcl-1, Correlates with Sensitivity to Combined Bcl-2/Bcl-xL Blockade
    Williams, Michelle M.
    Lee, Linus
    Hicks, Donna J.
    Joly, Meghan M.
    Elion, David
    Rahman, Bushra
    McKernan, Courtney
    Sanchez, Violeta
    Balko, Justin M.
    Stricker, Thomas
    Estrada, Monica Valeria
    Cook, Rebecca S.
    MOLECULAR CANCER RESEARCH, 2017, 15 (03) : 259 - 268
  • [23] Effective Targeting of Melanoma Cells by Combination of Mcl-1 and Bcl-2/Bcl-xL/Bcl-w Inhibitors
    Peng, Zhe
    Gillissen, Bernhard
    Richter, Antje
    Sinnberg, Tobias
    Schlaak, Max S.
    Eberle, Juergen
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (06)
  • [24] Evaluation of combined BCL-2/MCL-1 inhibition as a therapeutic approach for synovial sarcoma.
    Fairchild, Carter Kent
    Floros, Konstantinos
    Jacob, Sheeba
    Coon, Colin
    Puchalapalli, Madhavi
    Hu, Bin
    Dozmorov, Mikhail
    Koblinski, Jennifer
    Smith, Steven
    Domson, Gregory
    Ebi, Hiromichi
    Faber, Anthony
    Boikos, Sosipatros Alexandros
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [25] Targeting AML through apoptosis activation using Bcl-2/Mcl-1 or Bcl-2/Hdm2 inhibitor combination therapies
    Wang, Youzhen
    Qui, Shumei
    Sanghavi, Sneha
    Mulford, Lain
    Lysiak, Gaelle
    Chanrion, Maia
    Mistry, Prakash
    Pfaar, Ulrike
    Schoumacher, Marie
    Claperon, Audrey
    Kraus-Berthier, Laurence
    Banquet, Sebastien
    Derreal, Alix
    Fabre, Claire
    Maacke, Heiko
    Colland, Frederic
    Geneste, Olivier
    Morris, Erick
    Halilovic, Ensar
    CANCER RESEARCH, 2019, 79 (13)
  • [26] Epigenetic Targeting of Mcl-1 Is Synthetically Lethal with Bcl-xL/Bcl-2 Inhibition in Model Systems of Glioblastoma
    Shang, Enyuan
    Nguyen, Trang T. T.
    Shu, Chang
    Westhoff, Mike-Andrew
    Karpel-Massler, Georg
    Siegelin, Markus D.
    CANCERS, 2020, 12 (08) : 1 - 21
  • [27] Combined inhibition of BCL-2 and MCL-1 overcomes BAX deficiency-mediated resistance of TP53-mutant acute myeloid leukemia to individual BH3 mimetics
    Bing Z. Carter
    Po Yee Mak
    Wenjing Tao
    Edward Ayoub
    Lauren B. Ostermann
    Xuelin Huang
    Sanam Loghavi
    Steffen Boettcher
    Yuki Nishida
    Vivian Ruvolo
    Paul E. Hughes
    Phuong K. Morrow
    Torsten Haferlach
    Steven Kornblau
    Muharrem Muftuoglu
    Michael Andreeff
    Blood Cancer Journal, 13
  • [28] Pro-apoptotic carboxamide analogues of natural fislatifolic acid targeting Mcl-1 and Bcl-2
    Tiamas, Shelly Gapil
    Daressy, Florian
    Abou Samra, Alma
    Bignon, Jerome
    Steinmetz, Vincent
    Litaudon, Marc
    Fourneau, Christophe
    Leong, Kok Hoong
    Ariffin, Azhar
    Awang, Khalijah
    Desrat, Sandy
    Roussi, Fanny
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2020, 30 (07)
  • [29] Glutathione and Bcl-2 targeting facilitates elimination by chemoradiotherapy of human A375 melanoma xenografts overexpressing bcl-xl, bcl-2, and mcl-1
    Mena, Salvador
    Rodriguez, Maria L.
    Ortega, Angel
    Priego, Sonia
    Obrador, Elena
    Asensi, Miguel
    Petschen, Ignacio
    Cerda, Miguel
    Brown, Bob D.
    Estrela, Jose M.
    JOURNAL OF TRANSLATIONAL MEDICINE, 2012, 10
  • [30] Glutathione and Bcl-2 targeting facilitates elimination by chemoradiotherapy of human A375 melanoma xenografts overexpressing bcl-xl, bcl-2, and mcl-1
    Salvador Mena
    María L Rodriguez
    Angel Ortega
    Sonia Priego
    Elena Obrador
    Miguel Asensi
    Ignacio Petschen
    Miguel Cerdá
    Bob D Brown
    José M Estrela
    Journal of Translational Medicine, 10